Markers of nerve damage fell significantly in most patients after transplant
by Marisa Wexler – Multiple Sclerosis News Today
Autologous hematopoietic stem cell transplant (aHSCT) reduces markers of nerve fiber and myelin damage in people with relapsing-remitting MS (RRMS), according to a small study done in Sweden.
“We investigated if therapeutic intervention with aHSCT could halt the injurious process leading to tissue damage in MS,” researchers wrote. “Our main finding is that a majority of patients reach that goal with time, regardless of subsequent disease activity.”
The study, “Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis,” was published in Multiple Sclerosis and Related Disorders.